Rena Conti

University of Chicago

SCHOLARLY PAPERS

9

DOWNLOADS

223

SSRN CITATIONS
Rank 26,886

SSRN RANKINGS

Top 26,886

in Total Papers Citations

16

CROSSREF CITATIONS

17

Scholarly Papers (9)

1.

Pricing in the Market for Anticancer Drugs

NBER Working Paper No. w20867
Number of pages: 34 Posted: 20 Jan 2015
Emory University - Department of Health Policy and Management, Memorial Sloan Kettering Cancer Center - Department of Medicine, Massachusetts Institute of Technology (MIT) - Sloan School of Management and University of Chicago
Downloads 58 (418,219)
Citation 8

Abstract:

Loading...

2.

Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001-2007

NBER Working Paper No. w20016
Number of pages: 48 Posted: 31 Mar 2014 Last Revised: 30 Sep 2014
Rena Conti and Ernst R. Berndt
University of Chicago and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 51 (443,400)
Citation 2

Abstract:

Loading...

3.

The Landscape of Us Generic Prescription Drug Markets, 2004-2016

NBER Working Paper No. w23640
Number of pages: 64 Posted: 04 Aug 2017 Last Revised: 04 Feb 2021
Massachusetts Institute of Technology (MIT) - Sloan School of Management, University of Chicago and Massachusetts Institute of Technology (MIT)
Downloads 31 (532,800)
Citation 2

Abstract:

Loading...

4.

The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications

NBER Working Paper No. w26524
Number of pages: 53 Posted: 09 Dec 2019
Wellesley College, Wellesley College, University of Chicago and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 22 (587,055)

Abstract:

Loading...

5.

Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets

NBER Working Paper No. w26194
Number of pages: 44 Posted: 18 Sep 2019 Last Revised: 24 Sep 2019
Rena Conti and Ernst R. Berndt
University of Chicago and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 22 (587,055)
Citation 1

Abstract:

Loading...

6.

The Generic Drug User Fee Amendments: an Economic Perspective

NBER Working Paper No. w23642
Number of pages: 59 Posted: 11 Aug 2017 Last Revised: 06 Feb 2021
Massachusetts Institute of Technology (MIT) - Sloan School of Management, University of Chicago and Massachusetts Institute of Technology (MIT)
Downloads 21 (593,670)
Citation 4

Abstract:

Loading...

7.

The Effect of Fda Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts

NBER Working Paper No. w17528
Number of pages: 27 Posted: 22 Oct 2011 Last Revised: 28 Jul 2013
University of Chicago, affiliation not provided to SSRN and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 14 (641,522)

Abstract:

Loading...

8.

NBER Working Paper No. w26512
Number of pages: 42 Posted: 03 Dec 2019 Last Revised: 15 Jun 2020
Paolo Adajar, Ernst R. Berndt and Rena Conti
Massachusetts Institute of Technology (MIT) - Department of Economics, Massachusetts Institute of Technology (MIT) - Sloan School of Management and University of Chicago
Downloads 3 (722,429)
  • Add to Cart

Abstract:

Loading...

9.

Valuing Rare Pediatric Drugs: An Economics Perspective

NBER Working Paper No. w27978
Number of pages: 31 Posted: 27 Oct 2020
University of Chicago, Massachusetts Institute of Technology (MIT) - Department of Economics, affiliation not provided to SSRN and Tufts New England Medical Center (NEMC)
Downloads 1 (744,079)
  • Add to Cart

Abstract:

Loading...